Skip to main content



Home Introduction of Baked Egg after Oral Food Challenge Oct 2022 [Keet]

Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy Sept 2022 [Burks, Guo, Iweala, Kulis, Suber, Ye, Zhang]

Preventing allergies through the skin Sept 2022 [Keet, Winslow]

Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans Sept 2022 [Burks]

Longitudinal disease-associated gut microbiome differences in infants with food protein-induced allergic proctocolitis Sept 2022 [Virkud]

Peanut anaphylaxis in 2022: Decoupling epinephrine usage from emergency department evaluation Sept 2022 [Kim, Winslow]

Treatment for food allergy: Current status and unmet needs Aug 2022 [Kim]

Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy Aug 2022 [Burks, Kim, Kulis, Smeekens]

A “LEAP” forward in understanding immune mechanisms of oral tolerance to peanut Aug 2022 [Kulis, Moran]

Single-dose AAV vector gene immunotherapy to treat food allergy July 2022 [Kulis]

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results July 2022 [Kim]

Targeting CD22 on memory B cells to induce tolerance to peanut allergens July 2022 [Burks, Kulis, Hardy, Smeekens]

Evaluation of a group visit model for access to infant and toddler oral food challenges Jun 2022 [Virkud]

Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis Jun 2022 [Keet]

Comprehensive home environmental intervention did not reduce allergen concentrations or controller medication requirements among children in Baltimore Jun 2022 [Keet]

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy Jun 2022 [Kim]

Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials Jun 2022 [Burks]

Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy Jun 2022 [Burks, Guo, Hamilton, Herlihy, Keet, Kim, Kulis, Li, Smeekens, Ye, Yue]

Prospective associations between acid suppressive therapy and food allergy in early childhood May 2022 [Virkud]

Efficacy and safety of baked milk oral immunotherapy in children with severe milk allergy: A randomized, double-blind, placebo-controlled phase 2 trial Apr 2022 [Keet]

Effective methods of clinical education Mar 2022 [Kim]

The year in food allergy Mar 2022 [Keet]

Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts Apr 2022 [Burks, Kim]

Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study Jan 2022 [Burks, Kim, Kulis]

Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic Jan 2022 [Kulis]


Mouse Models of Food Allergy in the Pursuit of Novel Treatment Modalities Dec 2021 [Kulis, Smeekens]

Mapping Sequential IgE-Binding Epitopes on Major and Minor Egg Allergens Nov 2021 [Burks]

The airway as a route of sensitization to peanut: An update to the dual allergen exposure hypothesis Sept 2021 [Kulis, Moran, Smeekens]

Heterogeneity in Parent Preferences for Peanut Desensitization Therapy Sept 2021 [Kim]

Caregiver perceptions and attitudes associated with oral immunotherapy on social media Sept 2021 [Keet]

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study May 2021 [Burks]

Shorter “time to peanut introduction” can prevent peanut allergy and avert false Ara h 2 screening results in infants May 2021 [Iglesia, Kim]

Increasing diversity in peanut oral immunotherapy research and accessibility May 2021 [Kim]

Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research Mar 2021 [Burks, Kim]

Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible Mice Jan 2021 [Burks, Hinton, Kesselring, Kulis, Smeekens, Steinbach]

Timing of exposure to environmental adjuvants is critical to mitigate peanut allergy Jan 2021 [Kulis, Moran, Smeekens]

Current Insights into Immunotherapy Approaches for Food Allergy Jan 2021 [Burks, Kim]

Five-year follow-up of early intervention peanut oral immunotherapy Jan 2021 [Barber, Burks, Herlihy, Hamilton, Kim]

Mechanisms of oral immunotherapy Jan 2021 [Barshow, Burks, Kim, Kulis]

Irradiated Tree Nut Flours for Use in Oral Immunotherapy Jan 2021 [Burks, Kesselring, Kim, Kulis, Penumarti]


Model of Walnut Allergy in CC027/GeniUnc Mice Recapitulates Key Features of Human Disease Dec 2020 [Kesselring, Kulis, Smeekens]

Strategies for Mast Cell Inhibition in Food Allergy Dec 2020 [Iweala, Suber]

Early epitope-specific IgE antibodies are predictive of childhood peanut allergy Nov 2020 [Burks]

Irradiated Tree Nut Flours for Use in Oral Immunotherapy Nov 2020 [Burks, Kesselring, Kim, Kulis, Penumarti, Sheth]

Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research Oct 2020 [Burks, Kulis]

Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy Oct 2020 [Burks, Kim]

Dosing, safety, and quality of life after peanut immunotherapy trials: A long-term follow-up study Sept 2020 [Barber, Burks, Herlihy, Kim]

Timing of exposure to environmental adjuvants is critical to mitigate peanut allergy Sept 2020 [Kulis, Smeekens]

IgE producers in the gut expand the gut’s role in food allergy Jul 2020 [Burks, Iweala]

Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy Jun 2020 [Burks, Kim]

Legends of allergy and immunology: Hugh A. Sampson Jun 2020 [Burks]

A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol Apr 2020 [Burks, Kim]

Peanut applied to the skin of nonhuman primates induces antigen-specific IgG but not IgE Mar 2020 [Kulis, Smeekens]

Systematic quantification of the dynamics of newly synthesized proteins unveiling their degradation pathways in human cells Mar 2020 [Smeekens]

Immunotherapy approaches for peanut allergy Feb 2020 [Burks, Kim, Patel]

Evolution of Immune Responses in Food Immunotherapy Feb 2020 [Kulis, Smeekens]


Biomarkers in Food Allergy Immunotherapy Dec 2019 [Hardy, Kulis, Smeekens]

A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis Dec 2019 [Burks, Guo, Hamilton, Kulis]

Evolution of Immune Responses in Food Immunotherapy Nov 2019 [Kulis, Smeekens]

IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy Oct 2019 [Burks, Kulis]

Long-term sublingual immunotherapy for peanut allergy in children: Clinical and immunologic evidence of desensitization Sep 2019 [Burks, Guo, Kim, Kulis, Ye]

Indoor dust acts as an adjuvant to promote sensitization to peanut through the airway Sep 2019 [Kulis, Smeekens]

Clinical factors associated with peanut allergy in a high-risk infant cohort Jul 2019 [Burks]

Plant cell-made protein antigens for induction of Oral tolerance Jun 2019 [Kulis]

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods Apr 2019 [Burks]

Hypoallergenic Proteins for the Treatment of Food Allergy Feb 2019 [Kulis]

Dosing and Safety of Peanut Food Equivalents After Immunotherapy Trials Feb 2019 [Barber, Burks, Herlihy, Kim]

Back to Life, Back to Reality – What Happens after Peanut Immunotherapy? A Long-Term Follow up Study on Perceptions of Safety and Lifestyle Feb 2019 [Barber, Burks, Herlihy, Kim]

The Consortium for Food Allergy Research (CoFAR): The first generation Feb 2019 [Burks]


Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness Nov 2018 [Burks, Guo, Hardy, Kulis, Smeekens, Suber]

AR101 Oral Immunotherapy for Peanut Allergy Nov 2018 [Burks, Kim]

Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy Oct 2018 [Burks, Guo, Kulis, Smeekens, Ye]

Antigenic Liposomes for Generation of Disease-specific Antibodies Oct 2018 [Hardy, Kulis, Smeekens]

Adjuvanted Immunotherapy Approaches for Peanut Allergy Sep 2018 [Burks, Kulis]

High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children Sep 2018 [Burks, Guo, Kim, Kulis, Ye, Yue]

Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research Aug 2018 [Burks]

Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy Jul 2018 [Burks]

A Mouse Model of Peanut Allergy Induced by Sensitization Through the Gastrointestinal Tract Jun 2018 [Kulis]

Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector T H 2 subsets Jun 2018 [Burks]

Tree nut allergies: Allergen homology, cross-reactivity, and implications for therapy Jun 2018 [Kulis, Smeekens]

Characteristics of Preschool-Aged Children Currently Enrolled in a Phase II Double Blind Placebo Controlled Study of Peanut Sublingual Immunotherapy Feb 2018 [Burks, Herlihy, Kim]

A novel assessment of sustained unresponsiveness (SU) after long term sublingual immunotherapy (SLIT) in peanut allergic children: results of a 4 year phase II clinical trial Feb 2018 [Bennick, Burks, Hamilton, Herlihy, Kim]

Assessing the validity of an IRB approved REDCap web based clinical trials recruitment registry Feb 2018 [Bennick, English, Hamilton, Herlihy, Kim]



Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab Dec 2016 [Burks, Kulis]

Food allergen extracts to diagnose food-induced allergic diseases: How they are made Nov 2016 [Burks, Penumarti]

Mast cell desensitization inhibits calcium flux and aberrantly remodels actin Sep 2016 [Burks, Kulis]

Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2 Aug 2016 [Burks, Kulis]

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective Aug 2016 [Burks, Guo, Kim, Kulis, Ye]

Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness Jun 2016 [Burks, Kulis]

Peanut Allergy: New Developments and Clinical Implications May 2016 [Commins, Kim, Kulis]

The Seed Biotinylated Protein of Soybean (Glycine max): A Boiling-Resistant New Allergen (Gly m 7) with the Capacity To Induce IgE-Mediated Allergic Responses May 2016 [Burks, Kulis]

Food-specific IgG 4 is associated with eosinophilic esophagitis Apr 2016 [Burks, Guo, Kulis]

NMR-Based Metabolomics Analysis Reproducibly Identifies Unique Subject-Specific Profiles That Change during Peanut Oral Immunotherapy Feb 2016 [Burks, Hamilton, Kulis]

Basophil Activation and Peanut-Specific IgE Are Not Predictors of Threshold Dose during a Double-Blind Placebo-Controlled Food Challenge (DBPCFC) Feb 2016 [Burks, Guo, Hamilton, Kim, Ye]

Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy Feb 2016 [Burks, Kim, Kulis]



Prior to 2014